The pharmaceutical industry relies heavily on a robust pipeline of intermediates that enable the efficient synthesis of complex drug molecules. 4-(Hydroxymethyl)phenylacetic acid (CAS: 73401-74-8) is a prime example of such a critical compound, acting as a linchpin in the creation of various therapeutic agents.

As a key intermediate in pharmaceutical intermediate synthesis, 4-(Hydroxymethyl)phenylacetic acid offers a unique combination of functional groups that are highly amenable to further chemical modification. Its structural features are particularly advantageous for the development of analgesics and anti-inflammatory drugs, where precise molecular architecture is crucial for efficacy and safety. Researchers looking to advance drug development projects often seek to buy this compound, valuing its consistent quality and predictable reactivity. Sourcing from a reliable supplier like NINGBO INNO PHARMCHEM CO.,LTD. ensures the integrity of the subsequent synthesis steps.


The production of 4-(Hydroxymethyl)phenylacetic acid involves sophisticated chemical synthesis, aiming for high purity to meet stringent pharmaceutical standards. The methods employed, often including hydrolysis and careful purification, are designed to yield a product that is both effective and safe for use in drug manufacturing. The efficiency of these synthesis routes directly influences the availability and price of the compound, making it a focal point for chemical manufacturers.


NINGBO INNO PHARMCHEM CO.,LTD., as a dedicated manufacturer, understands the critical demands of the pharmaceutical sector. We are committed to providing high-purity 4-(Hydroxymethyl)phenylacetic acid, thereby supporting the innovation and production goals of pharmaceutical companies worldwide. Our role is to empower drug discovery by ensuring a consistent and reliable supply of this essential chemical building block.